Flightpath Biosciences

Flightpath Biosciences Develops Antibiotic Therapies for Treating Pathogen-Driven Diseases. The company's therapies target co-infecting bacteria in Lyme disease to minimize microbiome damage and address multiple pathogenic bacteria in the oral and gut microbiomes, offering patients a novel therapeutic approach to eradicate rare infectious diseases.